Zeckel, M L <br/><br/>
Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.  [electronic resource] 

 -  Clinical therapeutics   
 - 214-29 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0149-2918 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Amoxicillin--adverse effects<br/>Amoxicillin-Potassium Clavulanate Combination<br/>Bacterial Infections--drug therapy<br/>Bronchitis--drug therapy<br/>Cephalosporins--adverse effects<br/>Chronic Disease<br/>Clavulanic Acids--adverse effects<br/>Drug Therapy, Combination--adverse effects<br/>Female<br/>Haemophilus Infections--drug therapy<br/>Haemophilus influenzae<br/>Humans<br/>Male<br/>Middle Aged<br/>Moraxella catarrhalis<br/>Neisseriaceae Infections--drug therapy<br/>Pneumococcal Infections--drug therapy<br/>Single-Blind Method